Randomized Phase 11 Study of the Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab With Cisplatin Versus Cisplatin Alone in Patients With Metastatis Triple-Negative Breast Cancer - Baselga, J.; Gomez, P.; Greil, R.; Braga, S.; Climent, M.; Wardley, A.; Kaufman, B.; Stemmer, S.; Pego, A.; Chan, Arlene; Goeminne, J.; Graas, M.; et al. (American Society of Clinical Oncology, 2013)